Antimicrobial susceptibility of bacteria isolated from cows with mastitis in 2006-2007

• Autorzy: Malinowski E. , Lassa H. , Smulski S. , Klossowska A. , Kaczmarowski M.
• Języki publikacji: EN

Abstrakty

EN

The purpose of the study was determining the in vitro sensitivity of Streptococcus agalactiae, other Streptococcus sp., Staphylococcus aureus, coagulase-negative staphylococci, Escherichia coli, and Arcanobacterium pyogenes strains to antibiotics commonly used in veterinary praxis. These pathogens were isolated from cows with clinical or subclinical mastitis in 2006-2007. The activity of 10-14 antibiotics to each bacterial species was examined. The sensitivity was tested by disk diffusion method and performed according to CLSI guidelines in Mueller-Hinton agar. Streptococcus agalactiae strains were mostly sensitive to amoxicillin (93.6%), cefquinom (96%), cefapirin (94.1%), cefoperazone (88.9%), bacitracin (87.1%), and cephalexin (79%). Other streptococci were most susceptible to amoxicillin (91.4%), cefquinom (84.1%), bacitracin (89%), and cephalexin (79.7%). Amoxicillin/clavulanic acid (97.4%), cloxacillin (90%), cefquinom (92.9%), cephalexin (90.5%), and bacitracin (88.6%) were the most active against Staphylococcus aureus. Coagulase-negative staphylococci were sensitive to amoxicillin/clavulanic acid (100%), cefquinom (89.2%), cephalexin (89.3%), bacitracin (86.1%), rifaximin (86.8%), and cefapirin (86.5%). Norfloxacin (85.1%), enrofloxacin (83.9%), and marbofloxacin (84.4%) were active against Gram-negative bacilli. Only amoxicillin (87.1%) from ten analysed antibiotics exhibited very high activity against Arcanobacterium pyogenes.

• Wydawca: -
• Czasopismo: Bulletin of the Veterinary Institute in Puławy
• Rocznik: 2008
• Tom: 52
• Numer: 4
• Opis fizyczny: p.565-572,fig.,ref.

Twórcy

autor

Malinowski E.

• Department of Pathophysiology of Reproduction and Mammary Gland, National Veterinary Research Institute, 85-090 Bydgoszcz, Poland

autor

Lassa H.

• Department of Pathophysiology of Reproduction and Mammary Gland, National Veterinary Research Institute, 85-090 Bydgoszcz, Poland

autor

Smulski S.

• Department of Pathophysiology of Reproduction and Mammary Gland, National Veterinary Research Institute, 85-090 Bydgoszcz, Poland

autor

Klossowska A.

• Department of Pathophysiology of Reproduction and Mammary Gland, National Veterinary Research Institute, 85-090 Bydgoszcz, Poland

autor

Kaczmarowski M.

• Department of Pathophysiology of Reproduction and Mammary Gland, National Veterinary Research Institute, 85-090 Bydgoszcz, Poland

Bibliografia

• 1. Almeida R.A., Patel D., Friton G.M., Oliver S.P.: Intracellular killing of mastitis pathogens by penethemate hydriodide following internalization into mammary epithelial cell. J Vet Pharmacol Ther 2007, 30, 151-156.
• 2. Bar D., Tauer L.W., Bennett G., Gonzalez R.W., Hertl J.A., Schukken Y.H., Schulte H.F., Welcome F.L., Gröhn Y.T.: The cost of generic clinical mastitis in dairy cows as estimated by using dynamic programming. J Dairy Sci 2008, 91, 2205-2214.
• 3. Barkerna H.W., Schukken Y.H., Zadoks R.N.: Invited review. The role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis. J Dairy Sci 2006, 89, 1877-1895.
• 4. Bradley A.J., Leach K.A., Breen J.E., Green L.A., Green M.J.: Survey of the incidence and etiology of mastitis on dairy farms in England and Wales. Vet Rec 2004, 160, 253-257.
• 5. Burton J.L., Erskine R.J.: Immunity and mastitis. Some new ideas for an old disease. Vet Clin North Am Food Animal Pract 2003, 19, 1-45.
• 6. Constable P.D., Morin D.E.: Use of antimicrobial susceptibility testing of bacterial pathogens isolated from the milk of dairy cows with clinical mastitis to predict response to treatment with cephapirin and oxytetracycline. J Am Vet Med Assoc 2002, 221, 103- 108.
• 7. Corti S., Sicher D., Regli W.R.: Aktuelle Daten zur Antibiotikaresistenz der wichtigsten bovinen Mastitiserreger in der Schweiz. Schweiz Arch Tierheilk 2003, 145, 571-575.
• 8. Edelmann A., Pietzcker T., Wellinhausen N.: Comparison of direct disc diffusion and standard broth dilution susceptibility testing of blood culture isolates. J Med Microbiol 2007, 56, 202-207.
• 9. Erskine R.J., Walker R.D., Bolin C.A., Bartlett P.C., White D.S.: Trends in antibacterial susceptibility of mastitis pathogens during a seven-year period. J Dairy Sci 2002, 85, 1111-1118.
• 10. Ferguson J. D., Azzaro G., Gambina M., Licitra G.: Prevalence of mastitis pathogens in Ragusa, Sicily, from 2000 to 2006. J Dairy Sci 2007, 90, 5798-5913.
• 11. Fluit A.C., van der Bruggen J.T., Aarestrup F.M., Verhoef J., Sen W.T.M.: Priorities for antibiotic resistance surveillance in Europe. Clin Microbiol Infect 2006, 12, 410-417.
• 12. Gehring R., Smith G.W.: An overview of factors affecting the disposition of intramammary preparations used to treat bovine mastitis. J Vet Pharmacol Ther 2006, 29, 237-241.
• 13. Gosden P.E., Andrews J.M., Bowker K.E., Helt H.A., MacGowan A.P., Reeves D.S., Sunderland J., Wise P.: Comparison of modified Stokes' method of susceptibility testing with results obtained using MIC methods and British Society for Antimicrobial Chemotherapy breakpoints. J Antimicrob Chemother 1998, 42, 161-169.
• 14. Guérin-Faublée V., Carret G., Houpffschmitt P.: In vitro activity of 10 antimicrobial agents against bacteria isolated from cows with clinical mastitis. Vet Rec 2003, 152, 466-471.
• 15. Halasa T., Huijps K., Österas O., Hogeveen H.: Economic effects of bovine mastitis and mastitis management: a review. Vet Quart 2007, 29, 19-31.
• 16. Hoe F.S., Ruegg P.L.: Relationship between antimicrobial susceptibility of clinical mastitis pathogens and treatment outcome in cows. J Am Vet Med Assoc 2005, 227, 1461-1468.
• 17. Huijps K., Lam T.J.S.M., Hogeveen H.: Costs of mastitis: facts and perception. J Dairy Res 2008, 75, 113- 120.
• 18. Jost B.H., Field A.C., Trinh H.T., Songer J.S., Billington S.J.: Tylosin resistance in Arcanobacterium pyogenes is encoded by an er mx determinant. Antimicrob Agents Chemother 2003, 47, 3519-3524.
• 19. Klement E., Chaffer M., Leitner G., Shwimmer A., Friedman S., Saran A., Shpigel N.: Assessment of accuracy of disc diffusion tests for the determination of antimicrobial susceptibility of common bovine mastitis pathogens: a novel approach. Microb Drug Resist 2005, 11, 342-350.
• 20. Lehtolainen T., Shwimmer A., Shpigel N.Y., Honkanen- Buzalski T., Pyörälä S.: In vitro antimicrobial susceptibility of Escherichia coli isolates from clinical bovine mastitis in Finland and Israel. J Dairy Sci 2003, 86, 3927-3932.
• 21. Losinger W. C.: Economic impacts of reduced milk production associated with an increase in bulk-tank somatic cell count an US dairies. J Am Vet Med Assoc 2005, 226, 1652-1658.
• 22. Malinowski E., Pilaszek J., Kłossowska A., Sobolewska S., Sobolewski J.: Changes of the antibiotic-sensitivity of bacteria isolated from clinically manifested mastitis in dairy-cows during the period of 1987-1996. Vet Med 1997, 53, 722-725.
• 23. Malinowski E., Kłossowska A.: Diagnostyka zakażeń i zapaleń gruczołu mlekowego krów. Editor PIWet, Puławy, 2002.
• 24. Malinowski E., Kłossowska A.: Cow mastitis pathogen resistance to antibiotics. Vet Med 2003, 59, 230-235.
• 25. Malinowski E.: Trials for improvement of the efficacy of cows' clinical mastitis treatment - a overview. Achievements and Prospects of Ruminant Medicine. Editor PIWet, Pulawy, 2005, pp. 477-489.
• 26. Malinowski E., Lassa H., Kłossowska A., Markiewicz H., Kaczmarowski M., Smulski S.: Relationship between mastitis agents and somatic cell count in premilk samples. Bull Vet Inst Pulawy 2006, 50, 349-352.
• 27. Malinowski E., Niewitecki W., Nadolny M., Lassa H., Smulski S.: Effect of lysozyme dimer injections on results of intramammary treatment of acute mastitis in cows. Vet Med 2006, 62, 1395-1399.
• 28. Myllys V., Asplund K., Brofeldt E., Hirvelä-Koski V., Honkanen-Buzalski T., Juntilla J., Kulkas L., Myllykangas O., Niskanen M., Saloniemi H., Sandholm M., Saranpää T.: Bovine mastitis in Finland in 1998 and 1995 - changes in prevalence and antimicrobial resistance. Acta vet Scand 1998, 39, 119-126.
• 29. NCCLS. Performance Standards for Antimicrobial Susceptibility Testing. Eleventh Informational Supplement, NCCLS document M 100-911 (ISBN 1- 56238-426-0). NCCLS, 19087-1898, Pensylvania, USA, 2001.
• 30. Oliveira A.P.de, Watts J.L., Salmon S.A., Aerestrup F.M.: Antimicrobial susceptibility of Staphylococcus aureus isolated from bovine mastitis in Europe and in the United States. J Dairy Sci 2000, 83, 855-862.
• 31. Owens W.E., Ray C.H., Watts J.L.,Yancey R.J.: Comparison of success of antibiotic therapy during lactation and results of antimicrobial susceptibility tests for bovine mastitis. J Dairy Sci 1997, 80, 313-317.
• 32. Pitkälä A., Haveri M., Pyőrälä S., Myllys V., Hankonen- Buzalski T.: Bovine mastitis in Finland 2001- prevalence distribution of bacteria, and antimicrobial resistance. J Dairy Sci 2004, 87, 2433-2441.
• 33. Potz N.A.C., Mushtaq S., Johnson A.P., Henwood C.J., Walker R.A., Varey E., Warner M., James D., Livermore D.M.: Reliability of routine disc susceptibility testing by the British Society for Antimicrobial Chemotherapy (BSAC) method. J Antimicrob Chemother 2004, 53, 729- 738.
• 34. Rajala-Schultz P.J., Smith K.L., Hogan J.S., Love B.C.: Antimicrobial susceptibility of mastitis pathogens from first lactation and older cows. Vet Microbiol 2004, 102, 33-42.
• 35. Reddy P., Qi C., Zembower T., Noskin G.A., Bolon M.: Postpartum mastitis and community-acquired methicillin- resistant Staphylococcus aureus. Emerg Infect Dis 2007, 13, 298-301.
• 36. Reinard P., Riollet C.: Innate immunity of the bovine mammary gland. Vet Res 2006, 37, 369-400.
• 37. Sachanowicz J., Jakubczak A., Piechota M.: Phenotype and genotype traits of S. aureus strains isolated from mastitis milk samples. Vet Med 2005, 61, 1370-1373.
• 38. Schröder A., Hoedemaker M., Klein G.: Resistenzen von Mastitiserregern im norddeuschen Raum. Berl Münch Tierärztl Wochenschr 2005, 118, 393-398.
• 39. Schwarz S., Kehrenberg C., Walsh T.R.: Use of antimicrobial agents in veterinary medicine and food animal production. Int J Antimicrob Agents 2001, 17, 431-437.
• 40. Seegers H., Fourichon C., Beaudeqm F.: Production effects related to mastitis and mastitis economics in dairy cattle herds. Vet Res 2003, 34, 475-491.
• 41. Serieys F., Raguet Y., Coby L., Schmidt H., Friton G.: Comparative efficacy of local and systemic antibiotic treatment in lactating cows with clinical mastitis. J Dairy Sci 2005, 88, 93-99.
• 42. Smith G.W., Lyman R. L., Anderson K. L.: Efficacy of vaccination and antimicrobial treatment to eliminate chronic intramammary Staphylococcus aureus infections in dairy cattle. J Am Vet Med Assoc 2006, 228, 422-425.
• 43. Srinivasan V., Gillespie B.E., Lewis M.J., Nguven L.T., Headrick S.J., Schukken Y.H., Oliver S.P.: Phenotypic and genotypie antimicrobial resistance patterns of Escherichia coli isolated from dairy cows with mastitis. Vet Microbiol 2007, 124, 319-328.
• 44. Turutoglu H., Ercelik S., Ozturk D.: Antibiotic resistance of Staphylococcus aureus and coagulase-negative staphylococci isolated from bovine mastitis. Bull Vet Inst Pulawy 2006, 50, 41-45.
• 45. Waage S., Skei H.R., Rise J., Rogolo T., Sviland S., Odegaard S.A.: Outcome of clinical mastitis in dairy heifers assessed by reexamination of cases one month after treatment. J Dairy Sci 2000, 83, 70-76.
• 46. Yoshimura H., Kojima A., Ishimuru M.: Antimicrobial susceptibility of Arcanobacterium pyogenes isolated from cattle and pigs. J Vet Med B 2000, 47, 139-143.